HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=registry_id&start=45000",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=registry_id&start=44400",
"results": [
{
"registry_id": "NCT06175767",
"publication_url": "https://clinicaltrials.gov/study/NCT06175767",
"title": "A Phase IIa, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects With Early Parkinson's Disease",
"has_exemption": false,
"start_date": "2027-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mthera Pharma Co., Ltd.",
"sponsor_slug": "mthera-pharma-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228039",
"publication_url": "https://clinicaltrials.gov/study/NCT07228039",
"title": "A Double-Blind Prospective RCT Assessment of ESP Blocks for Analgesia Following Posterior Spinal Fusion",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01515527",
"publication_url": "https://clinicaltrials.gov/study/NCT01515527",
"title": "Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)",
"has_exemption": false,
"start_date": "2012-02-07",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04107181",
"publication_url": "https://clinicaltrials.gov/study/NCT04107181",
"title": "A Pilot Study Continuation to Assess the Use of an Introducer \"Calla\" During Cervical Cancer Screening",
"has_exemption": false,
"start_date": "2016-04-14",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02977780",
"publication_url": "https://clinicaltrials.gov/study/NCT02977780",
"title": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
"has_exemption": false,
"start_date": "2017-02-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "David Reardon, MD",
"sponsor_slug": "david-reardon-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03934372",
"publication_url": "https://clinicaltrials.gov/study/NCT03934372",
"title": "An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors in Pediatric Participants",
"has_exemption": false,
"start_date": "2020-01-29",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Biosciences International Sàrl",
"sponsor_slug": "incyte-biosciences-international-sarl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04620187",
"publication_url": "https://clinicaltrials.gov/study/NCT04620187",
"title": "A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas",
"has_exemption": false,
"start_date": "2020-12-24",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05858619",
"publication_url": "https://clinicaltrials.gov/study/NCT05858619",
"title": "Molecular Signatures of Cutaneous Dupilumab Response",
"has_exemption": false,
"start_date": "2023-02-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05039632",
"publication_url": "https://clinicaltrials.gov/study/NCT05039632",
"title": "Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949099",
"publication_url": "https://clinicaltrials.gov/study/NCT05949099",
"title": "Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor",
"has_exemption": false,
"start_date": "2023-08-15",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nam Bui",
"sponsor_slug": "nam-bui",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819853",
"publication_url": "https://clinicaltrials.gov/study/NCT05819853",
"title": "Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05386394",
"publication_url": "https://clinicaltrials.gov/study/NCT05386394",
"title": "Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06190717",
"publication_url": "https://clinicaltrials.gov/study/NCT06190717",
"title": "Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial",
"has_exemption": false,
"start_date": "2024-02-21",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sonavex, Inc.",
"sponsor_slug": "sonavex-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06287736",
"publication_url": "https://clinicaltrials.gov/study/NCT06287736",
"title": "A Novel Neuromodulation Approach to Target Small Fiber Neuropathy Early in Diabetes and Measure Functional Recovery",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06127407",
"publication_url": "https://clinicaltrials.gov/study/NCT06127407",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens",
"has_exemption": false,
"start_date": "2024-07-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336655",
"publication_url": "https://clinicaltrials.gov/study/NCT06336655",
"title": "Physiology of Unloading VA ECMO Trial",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617858",
"publication_url": "https://clinicaltrials.gov/study/NCT06617858",
"title": "Open-label Phase 2 Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment",
"has_exemption": false,
"start_date": "2024-12-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645106",
"publication_url": "https://clinicaltrials.gov/study/NCT06645106",
"title": "Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940180",
"publication_url": "https://clinicaltrials.gov/study/NCT06940180",
"title": "Perioperative Chemoimmunotherapy With Toripalimab for Sinonasal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05999383",
"publication_url": "https://clinicaltrials.gov/study/NCT05999383",
"title": "Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04433572",
"publication_url": "https://clinicaltrials.gov/study/NCT04433572",
"title": "Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercator MedSystems, Inc.",
"sponsor_slug": "mercator-medsystems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445166",
"publication_url": "https://clinicaltrials.gov/study/NCT06445166",
"title": "A Multicenter Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Adults",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133425",
"publication_url": "https://clinicaltrials.gov/study/NCT07133425",
"title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-11-06",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07085338",
"publication_url": "https://clinicaltrials.gov/study/NCT07085338",
"title": "A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213466",
"publication_url": "https://clinicaltrials.gov/study/NCT07213466",
"title": "Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo",
"has_exemption": false,
"start_date": "2026-01-19",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07636720",
"publication_url": "https://clinicaltrials.gov/study/NCT07636720",
"title": "Sensing in Sleep and Deep Brain Stimulation",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06674109",
"publication_url": "https://clinicaltrials.gov/study/NCT06674109",
"title": "SAVE-Care (SGLT2i As Novel Gout Care) Trial",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441122",
"publication_url": "https://clinicaltrials.gov/study/NCT07441122",
"title": "Building Cognitive Reserve Through Brain-Computer-Interfaces",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07009899",
"publication_url": "https://clinicaltrials.gov/study/NCT07009899",
"title": "BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461961",
"publication_url": "https://clinicaltrials.gov/study/NCT07461961",
"title": "CORTISHOCK-P: A Randomized Pilot Trial of Corticosteroids as a Pharmacologic Adjunct to Temporary Mechanical Circulatory Support in Inflammation-Enriched Heart Failure Cardiogenic Shock",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07701785",
"publication_url": "https://clinicaltrials.gov/study/NCT07701785",
"title": "Accelerated Intermittent Theta Burst Stimulation for Mild Cognitive Impairment in Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02332668",
"publication_url": "https://clinicaltrials.gov/study/NCT02332668",
"title": "A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)",
"has_exemption": false,
"start_date": "2015-03-19",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/study/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205822",
"publication_url": "https://clinicaltrials.gov/study/NCT07205822",
"title": "A Phase IIIb, Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HRpositive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216027",
"publication_url": "https://clinicaltrials.gov/study/NCT07216027",
"title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08049820 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07768345",
"publication_url": "https://clinicaltrials.gov/study/NCT07768345",
"title": "A PHASE 3, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATION WITH RESPIRATORY SYNCYTIAL VIRUS STABILIZED PREFUSION F SUBUNIT VACCINE (RSVPREF) IN IMMUNOCOMPROMISED ADULTS",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813911",
"publication_url": "https://clinicaltrials.gov/study/NCT06813911",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C and Lp(a)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219407",
"publication_url": "https://clinicaltrials.gov/study/NCT07219407",
"title": "An Open-label, Long-term Study Evaluating RAP-219 in Adult Participants With Refractory Onset Seizures",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223138",
"publication_url": "https://clinicaltrials.gov/study/NCT07223138",
"title": "A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "MoonLake Immunotherapeutics AG",
"sponsor_slug": "moonlake-immunotherapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05075980",
"publication_url": "https://clinicaltrials.gov/study/NCT05075980",
"title": "HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers",
"has_exemption": false,
"start_date": "2022-02-16",
"completion_date": "2028-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05874401",
"publication_url": "https://clinicaltrials.gov/study/NCT05874401",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan Chemotherapy",
"has_exemption": false,
"start_date": "2023-10-13",
"completion_date": "2028-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmacosmos A/S",
"sponsor_slug": "pharmacosmos-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112872",
"publication_url": "https://clinicaltrials.gov/study/NCT07112872",
"title": "A Randomized, Double-Blind, Placebo- and Open-Label Active Comparator- Controlled, Parallel-Group, Multi-Center Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Daily RO7795081 Administered for 30 Weeks to Participants With Type 2 Diabetes Mellitus",
"has_exemption": false,
"start_date": "2025-08-19",
"completion_date": "2028-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173924",
"publication_url": "https://clinicaltrials.gov/study/NCT03173924",
"title": "Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2017-06-06",
"completion_date": "2028-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082543",
"publication_url": "https://clinicaltrials.gov/study/NCT07082543",
"title": "18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Azafaros B.V.",
"sponsor_slug": "azafaros-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05417594",
"publication_url": "https://clinicaltrials.gov/study/NCT05417594",
"title": "A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (CERTIS1)",
"has_exemption": false,
"start_date": "2022-06-24",
"completion_date": "2028-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091254",
"publication_url": "https://clinicaltrials.gov/study/NCT06091254",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 Bispecific Antibody Versus Investigator's Choice in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-1)",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03946878",
"publication_url": "https://clinicaltrials.gov/study/NCT03946878",
"title": "An Open Label, Phase II Investigator Initiated Study of Venetoclax and Acalabrutinib in Previously Treated Relapsed/Refractory Patients With Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456463",
"publication_url": "https://clinicaltrials.gov/study/NCT06456463",
"title": "A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07706504",
"publication_url": "https://clinicaltrials.gov/study/NCT07706504",
"title": "Comparison of Two Quantitative Electromyography Monitors for Deep Neuro Muscular Block in Patients Undergoing Abdominal Laparoscopic/Robotic or Thoracic Video-Assisted (VATS) Surgeries",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686120",
"publication_url": "https://clinicaltrials.gov/study/NCT07686120",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Baxdrostat on Ambulatory Blood Pressure in Chinese Participants With Uncontrolled Hypertension on Two or More Antihypertensive Medications Without Diuretics",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219043",
"publication_url": "https://clinicaltrials.gov/study/NCT07219043",
"title": "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-02-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708754",
"publication_url": "https://clinicaltrials.gov/study/NCT06708754",
"title": "PBM-LEF Study: The Impact of PBM on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients: A Feasibility Study",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2028-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201066",
"publication_url": "https://clinicaltrials.gov/study/NCT05201066",
"title": "An Open-label, Multicenter, Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.",
"has_exemption": false,
"start_date": "2023-02-28",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581198",
"publication_url": "https://clinicaltrials.gov/study/NCT06581198",
"title": "A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients With Active, Refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN).",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747585",
"publication_url": "https://clinicaltrials.gov/study/NCT06747585",
"title": "A Phase I/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+Squamous Solid Tumors",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alentis Therapeutics AG",
"sponsor_slug": "alentis-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948448",
"publication_url": "https://clinicaltrials.gov/study/NCT06948448",
"title": "A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo® in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care for First-line Treatment of Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169578",
"publication_url": "https://clinicaltrials.gov/study/NCT07169578",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07170150",
"publication_url": "https://clinicaltrials.gov/study/NCT07170150",
"title": "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214298",
"publication_url": "https://clinicaltrials.gov/study/NCT07214298",
"title": "A Phase I/II Study of Complement Inhibition in Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415031",
"publication_url": "https://clinicaltrials.gov/study/NCT07415031",
"title": "Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845500",
"publication_url": "https://clinicaltrials.gov/study/NCT07845500",
"title": "A PHASE 3 STUDY TO EVALUATE THE SWITCH TO MONTHLY BEROBENATIDE FOR MAINTAINING WEIGHT IN ADULTS WHO ARE ON WEEKLY SEMAGLUTIDE OR TIRZEPATIDE (VESPER-SWITCH)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706622",
"publication_url": "https://clinicaltrials.gov/study/NCT06706622",
"title": "Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627244",
"publication_url": "https://clinicaltrials.gov/study/NCT06627244",
"title": "Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931990",
"publication_url": "https://clinicaltrials.gov/study/NCT06931990",
"title": "A Phase Ic/II Clinical Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of Multiple Oral Doses of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.",
"sponsor_slug": "leadingtac-pharmaceutical-shaoxing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03850418",
"publication_url": "https://clinicaltrials.gov/study/NCT03850418",
"title": "Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2019-07-01",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Henry Ford Health System",
"sponsor_slug": "henry-ford-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843434",
"publication_url": "https://clinicaltrials.gov/study/NCT06843434",
"title": "A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06512883",
"publication_url": "https://clinicaltrials.gov/study/NCT06512883",
"title": "Phase 3, Open-label Trial to Evaluate Safety, Pharmacokinetics, and Efficacy of Benralizumab in Children With Eosinophilic Diseases (CLIPS)",
"has_exemption": false,
"start_date": "2025-04-17",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947941",
"publication_url": "https://clinicaltrials.gov/study/NCT06947941",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Psychosis Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2028-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439485",
"publication_url": "https://clinicaltrials.gov/study/NCT06439485",
"title": "Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244263",
"publication_url": "https://clinicaltrials.gov/study/NCT07244263",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07779408",
"publication_url": "https://clinicaltrials.gov/study/NCT07779408",
"title": "A Phase 1/2, Parallel, Observer-blind Study to Assess the Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07770841",
"publication_url": "https://clinicaltrials.gov/study/NCT07770841",
"title": "Efficacy and Safety of Once Daily Oral Semaglutide in Adults With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-08-12",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04083495",
"publication_url": "https://clinicaltrials.gov/study/NCT04083495",
"title": "Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma",
"has_exemption": false,
"start_date": "2019-09-17",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06198712",
"publication_url": "https://clinicaltrials.gov/study/NCT06198712",
"title": "A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2023-01-12",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Forma Therapeutics, Inc.",
"sponsor_slug": "forma-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07564414",
"publication_url": "https://clinicaltrials.gov/study/NCT07564414",
"title": "A Clinical Study to Compare Efficacy and Safety of Two Different Doses of CagriSema and Semaglutide in Participants With Obesity With or Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06268873",
"publication_url": "https://clinicaltrials.gov/study/NCT06268873",
"title": "A Phase III, Randomised, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants With CKD and High Blood Pressure",
"has_exemption": false,
"start_date": "2024-03-29",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866405",
"publication_url": "https://clinicaltrials.gov/study/NCT06866405",
"title": "A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744920",
"publication_url": "https://clinicaltrials.gov/study/NCT06744920",
"title": "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096908",
"publication_url": "https://clinicaltrials.gov/study/NCT07096908",
"title": "Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Dasman Diabetes Institute",
"sponsor_slug": "dasman-diabetes-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318597",
"publication_url": "https://clinicaltrials.gov/study/NCT07318597",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN13335, an Anti-PDGF-B Monoclonal Antibody, in Adults With Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07862530",
"publication_url": "https://clinicaltrials.gov/study/NCT07862530",
"title": "Phase II Trial of Neoadjuvant RP2 + Nivolumab in Patients With Resectable Melanoma",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Yana Najjar",
"sponsor_slug": "yana-najjar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02162849",
"publication_url": "https://clinicaltrials.gov/study/NCT02162849",
"title": "The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity",
"has_exemption": false,
"start_date": "2015-12-14",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03074812",
"publication_url": "https://clinicaltrials.gov/study/NCT03074812",
"title": "Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03438747",
"publication_url": "https://clinicaltrials.gov/study/NCT03438747",
"title": "An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CeraPedics, Inc",
"sponsor_slug": "cerapedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03586453",
"publication_url": "https://clinicaltrials.gov/study/NCT03586453",
"title": "A Phase II Study of Osimertinib With On-study and Post-progression Biopsy in the First Line Treatment of EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer",
"has_exemption": false,
"start_date": "2018-08-13",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887715",
"publication_url": "https://clinicaltrials.gov/study/NCT03887715",
"title": "A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LivaNova",
"sponsor_slug": "livanova",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03282396",
"publication_url": "https://clinicaltrials.gov/study/NCT03282396",
"title": "Phase II Trial of Ibrutinib in Perviously Untreated High Risk Smoldering Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2020-06-08",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04610866",
"publication_url": "https://clinicaltrials.gov/study/NCT04610866",
"title": "Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04380545",
"publication_url": "https://clinicaltrials.gov/study/NCT04380545",
"title": "A Phase I/II Study of Nivolumab Plus 5-Fluorouracil Plus Interferon-α2b for Unresectable Fibrolamellar Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2021-01-13",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04931342",
"publication_url": "https://clinicaltrials.gov/study/NCT04931342",
"title": "A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04712539",
"publication_url": "https://clinicaltrials.gov/study/NCT04712539",
"title": "Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05037760",
"publication_url": "https://clinicaltrials.gov/study/NCT05037760",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination With Ruxolitinib in Participants With Myelofibrosis",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064280",
"publication_url": "https://clinicaltrials.gov/study/NCT05064280",
"title": "Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases",
"has_exemption": false,
"start_date": "2022-01-20",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05470205",
"publication_url": "https://clinicaltrials.gov/study/NCT05470205",
"title": "Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension",
"has_exemption": false,
"start_date": "2022-11-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05594992",
"publication_url": "https://clinicaltrials.gov/study/NCT05594992",
"title": "An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects",
"has_exemption": false,
"start_date": "2023-02-22",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "JCR Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jcr-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05816382",
"publication_url": "https://clinicaltrials.gov/study/NCT05816382",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05546554",
"publication_url": "https://clinicaltrials.gov/study/NCT05546554",
"title": "Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06331052",
"publication_url": "https://clinicaltrials.gov/study/NCT06331052",
"title": "3-D Tractography Focused Ultrasound Ablation for Essential Tremor",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987644",
"publication_url": "https://clinicaltrials.gov/study/NCT05987644",
"title": "DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Joshua Palmer",
"sponsor_slug": "joshua-palmer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964269",
"publication_url": "https://clinicaltrials.gov/study/NCT06964269",
"title": "A Phase 4 Pilot Study With Extension to Assess the Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease and the Effect on Corneal Nerves and Neuropathic Corneal Pain",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Toyos Clinic",
"sponsor_slug": "toyos-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831149",
"publication_url": "https://clinicaltrials.gov/study/NCT06831149",
"title": "A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Spector",
"sponsor_slug": "matthew-spector",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855498",
"publication_url": "https://clinicaltrials.gov/study/NCT06855498",
"title": "A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810375",
"publication_url": "https://clinicaltrials.gov/study/NCT06810375",
"title": "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819670",
"publication_url": "https://clinicaltrials.gov/study/NCT06819670",
"title": "A Multicenter Pilot Clinical Trial to Prevent Infantile Spasms Relapse",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06600698",
"publication_url": "https://clinicaltrials.gov/study/NCT06600698",
"title": "Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218679",
"publication_url": "https://clinicaltrials.gov/study/NCT07218679",
"title": "Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla",
"sponsor_slug": "fundacion-publica-andaluza-para-la-gestion-de-la-investigacion-en-sevilla",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817018",
"publication_url": "https://clinicaltrials.gov/study/NCT06817018",
"title": "Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Shen",
"sponsor_slug": "leslie-shen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287917",
"publication_url": "https://clinicaltrials.gov/study/NCT07287917",
"title": "A Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination With Standard of Care in Patients With Advanced Solid Tumors Who Progressed After Prior Therapies",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Aminex Therapeutics, Inc.",
"sponsor_slug": "aminex-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07406360",
"publication_url": "https://clinicaltrials.gov/study/NCT07406360",
"title": "A Phase 3a, Observer Blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Combined Measles, Mumps, Rubella, and Varicella Vaccine Compared With Intramuscular Administration of ProQuad When Administered as a Second Dose to Healthy Children Aged 15 Months to 6 Years of Age",
"has_exemption": false,
"start_date": "2026-05-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07598396",
"publication_url": "https://clinicaltrials.gov/study/NCT07598396",
"title": "A Phase II Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Mosunetuzumab in Patients With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-05-25",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07811726",
"publication_url": "https://clinicaltrials.gov/study/NCT07811726",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of NT-101 Topical Ophthalmic Solution in Patients With Wet Age-Related Macular Degeneration (AMD)",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "NexThera Co., Ltd.",
"sponsor_slug": "nexthera-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07568535",
"publication_url": "https://clinicaltrials.gov/study/NCT07568535",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Mesoblast, Ltd.",
"sponsor_slug": "mesoblast-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07680478",
"publication_url": "https://clinicaltrials.gov/study/NCT07680478",
"title": "Assessing Nutrition-aligned Resmetirom Roll-out",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "City University of New York",
"sponsor_slug": "city-university-of-new-york",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833206",
"publication_url": "https://clinicaltrials.gov/study/NCT03833206",
"title": "A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients: Part I Dose Escalation",
"has_exemption": false,
"start_date": "2027-01-15",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "BioLite, Inc.",
"sponsor_slug": "biolite-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06473558",
"publication_url": "https://clinicaltrials.gov/study/NCT06473558",
"title": "Identification of Depressive and Anxiety Symptoms Among a Sample of Emergency Department Patients Using Artificial Intelligence (AI) Technology",
"has_exemption": false,
"start_date": "2027-02-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593456",
"publication_url": "https://clinicaltrials.gov/study/NCT07593456",
"title": "Investigating a Gamified NegatIve-symptom Therapeutic Based on Evidence-based Cognitive Therapy (IGNITE)",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "North Shore Therapeutics, Inc.",
"sponsor_slug": "north-shore-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948084",
"publication_url": "https://clinicaltrials.gov/study/NCT06948084",
"title": "A Randomized Phase II Trial for High-Risk Multiple Myeloma That is Refractory or in First Relapse With Daratumumab, Teclistamab (DT) Versus Daratumumab, Pomalidomide, Dexamethasone (DPd) or Daratumumab, Carfilzomib, Dexamethasone (DKd)",
"has_exemption": false,
"start_date": "2027-05-22",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02679144",
"publication_url": "https://clinicaltrials.gov/study/NCT02679144",
"title": "NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03093116",
"publication_url": "https://clinicaltrials.gov/study/NCT03093116",
"title": "A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)",
"has_exemption": false,
"start_date": "2017-03-07",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Turning Point Therapeutics, Inc.",
"sponsor_slug": "turning-point-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04524611",
"publication_url": "https://clinicaltrials.gov/study/NCT04524611",
"title": "A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337580",
"publication_url": "https://clinicaltrials.gov/study/NCT04337580",
"title": "A Phase II Trial of FASN Inhibition by Omeprazole in Combination With Cabazitaxel in Patients With Docetaxel- and Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04661137",
"publication_url": "https://clinicaltrials.gov/study/NCT04661137",
"title": "A Phase 2B Study of Selinexor (KPT-330), in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma Relapsing on Current Therapy",
"has_exemption": false,
"start_date": "2021-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04713475",
"publication_url": "https://clinicaltrials.gov/study/NCT04713475",
"title": "Phase 1/2 Open-Label, Multicenter Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered Into the Cisterna Magna of Pediatric Type 1 (Early Onset) and Type 2a (Late Onset) Infantile GM1 Gangliosidosis",
"has_exemption": false,
"start_date": "2021-03-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Gemma Biotherapeutics",
"sponsor_slug": "gemma-biotherapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04779554",
"publication_url": "https://clinicaltrials.gov/study/NCT04779554",
"title": "A Randomized Phase 2 Trial of Flat Dose vs. Weight-based Dose of Intra-peritoneal (IP) Chemotherapy for Patients Undergoing Cytoreductive Surgery and Heated Intra-peritoneal Chemotherapy (CRS/HIPEC) for Advanced Gastrointestinal Malignancy",
"has_exemption": false,
"start_date": "2021-06-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Prakash Pandalai",
"sponsor_slug": "prakash-pandalai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130450",
"publication_url": "https://clinicaltrials.gov/study/NCT05130450",
"title": "An Open-Label Extension Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)",
"has_exemption": false,
"start_date": "2021-11-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04704505",
"publication_url": "https://clinicaltrials.gov/study/NCT04704505",
"title": "Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD Study)",
"has_exemption": false,
"start_date": "2022-04-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05456880",
"publication_url": "https://clinicaltrials.gov/study/NCT05456880",
"title": "A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients With Sickle Cell Disease and Severe Vaso-Occlusive Crises (Beacon Trial)",
"has_exemption": false,
"start_date": "2022-08-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Beam Therapeutics Inc.",
"sponsor_slug": "beam-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05573126",
"publication_url": "https://clinicaltrials.gov/study/NCT05573126",
"title": "A Modular, Open-Label, Multi-Centre Phase 1/2 Dose-Finding, Optimisation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0062 as Monotherapy and in Combination in Patients With Relapsed Locally Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer",
"has_exemption": false,
"start_date": "2023-01-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellipses Pharma",
"sponsor_slug": "ellipses-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05654922",
"publication_url": "https://clinicaltrials.gov/study/NCT05654922",
"title": "A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant",
"has_exemption": false,
"start_date": "2023-04-10",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Renovion, Inc.",
"sponsor_slug": "renovion-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05783609",
"publication_url": "https://clinicaltrials.gov/study/NCT05783609",
"title": "A Phase 2 Study of Epcoritamab and Rituximab for First-line Treatment of Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06021522",
"publication_url": "https://clinicaltrials.gov/study/NCT06021522",
"title": "A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder",
"has_exemption": false,
"start_date": "2023-08-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emalex Biosciences Inc.",
"sponsor_slug": "emalex-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007183",
"publication_url": "https://clinicaltrials.gov/study/NCT06007183",
"title": "A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (CHIKV VLP) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05537896",
"publication_url": "https://clinicaltrials.gov/study/NCT05537896",
"title": "Prospective Evaluation of Xerava™ (Eravacycline) Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260709",
"publication_url": "https://clinicaltrials.gov/study/NCT06260709",
"title": "Open-label Extension Study of Long-term Safety and Efficacy of NNC6019-0001 in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR CM)",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161025",
"publication_url": "https://clinicaltrials.gov/study/NCT06161025",
"title": "A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2024-02-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191562",
"publication_url": "https://clinicaltrials.gov/study/NCT06191562",
"title": "Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "David Chi, MD",
"sponsor_slug": "david-chi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158854",
"publication_url": "https://clinicaltrials.gov/study/NCT06158854",
"title": "An Open-Label Phase 1/2 Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111781",
"publication_url": "https://clinicaltrials.gov/study/NCT06111781",
"title": "The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384807",
"publication_url": "https://clinicaltrials.gov/study/NCT06384807",
"title": "A Phase 1/2, First in Human, Dose Escalation and Dose Expansion Study of BHV-1510 (Previously PBI-410) as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biohaven Therapeutics Ltd.",
"sponsor_slug": "biohaven-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681195",
"publication_url": "https://clinicaltrials.gov/study/NCT05681195",
"title": "Zanubrutinib With Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial With a Safety Lead-In",
"has_exemption": false,
"start_date": "2024-04-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504147",
"publication_url": "https://clinicaltrials.gov/study/NCT06504147",
"title": "A Phase 2, Randomised, Open Label, Multicentre Study of an Intraperitoneal α-emitting Radionuclide Therapy (Radspherin®) in Patients With Primary Advanced High-grade Serous or High-grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient and Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery",
"has_exemption": false,
"start_date": "2024-06-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Oncoinvent Solutions AS",
"sponsor_slug": "oncoinvent-solutions-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06496178",
"publication_url": "https://clinicaltrials.gov/study/NCT06496178",
"title": "A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus B.V.",
"sponsor_slug": "merus-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06437574",
"publication_url": "https://clinicaltrials.gov/study/NCT06437574",
"title": "Lowering Cholesterol in Prostate Cancer to Target Rapamycin-Insensitive Companion Of MTOR (TORC2) in T-Cell Surface Glycoprotein CD8 Alpha Chain (CD8+) Lymphocytes",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06388083",
"publication_url": "https://clinicaltrials.gov/study/NCT06388083",
"title": "A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Belite Bio, Inc",
"sponsor_slug": "belite-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455787",
"publication_url": "https://clinicaltrials.gov/study/NCT06455787",
"title": "J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "JC Medical, Inc., an affiliate of Edwards Lifesciences LLC",
"sponsor_slug": "jc-medical-inc-an-affiliate-of-edwards-lifesciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310031",
"publication_url": "https://clinicaltrials.gov/study/NCT06310031",
"title": "Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BrioHealth Solutions, Inc.",
"sponsor_slug": "briohealth-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336798",
"publication_url": "https://clinicaltrials.gov/study/NCT06336798",
"title": "Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568939",
"publication_url": "https://clinicaltrials.gov/study/NCT06568939",
"title": "A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092333",
"publication_url": "https://clinicaltrials.gov/study/NCT06092333",
"title": "A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699602",
"publication_url": "https://clinicaltrials.gov/study/NCT06699602",
"title": "A Pilot Phase II Study of Neoadjuvant Cemiplimab + Fianlimab in Patients With Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534060",
"publication_url": "https://clinicaltrials.gov/study/NCT06534060",
"title": "A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).",
"has_exemption": false,
"start_date": "2025-02-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "March Biosciences Inc",
"sponsor_slug": "march-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902311",
"publication_url": "https://clinicaltrials.gov/study/NCT06902311",
"title": "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475781",
"publication_url": "https://clinicaltrials.gov/study/NCT06475781",
"title": "A Multinational Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Mirivadelgat, an Aldehyde Dehydrogenase 2 Activator, in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Foresee Pharmaceuticals Co., Ltd.",
"sponsor_slug": "foresee-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824792",
"publication_url": "https://clinicaltrials.gov/study/NCT06824792",
"title": "Real-world Study to Investigate Optimal Standard Treatment Selection for Solid Tumor Patients by Guided by Biologically-informed Multi-agent System",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "NING LI",
"sponsor_slug": "ning-li",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06522737",
"publication_url": "https://clinicaltrials.gov/study/NCT06522737",
"title": "A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SecuraBio",
"sponsor_slug": "securabio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730283",
"publication_url": "https://clinicaltrials.gov/study/NCT05730283",
"title": "Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin Therapy for Non-Tuberculous Mycobacterium Disease",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Winthrop",
"sponsor_slug": "kevin-winthrop",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995677",
"publication_url": "https://clinicaltrials.gov/study/NCT06995677",
"title": "A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801639",
"publication_url": "https://clinicaltrials.gov/study/NCT06801639",
"title": "Advancing Alzheimer's Care: Home-based tDCS (Transcranial Direct Current Stimulator) for Affective Symptoms",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721013",
"publication_url": "https://clinicaltrials.gov/study/NCT06721013",
"title": "A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults With Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055594",
"publication_url": "https://clinicaltrials.gov/study/NCT07055594",
"title": "A Phase I/IIa Dose-escalation, Dose-optimization and Dose Expansion Study to Evaluate the Safety and Preliminary Efficacy of Tri-specific Antibody (SOA101) in Subjects With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Shine-On Biomedical Co., Ltd.",
"sponsor_slug": "shine-on-biomedical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145918",
"publication_url": "https://clinicaltrials.gov/study/NCT07145918",
"title": "An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029581",
"publication_url": "https://clinicaltrials.gov/study/NCT07029581",
"title": "A Double-Blind, Placebo-Controlled, Phase 2, Efficacy and Safety Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925321",
"publication_url": "https://clinicaltrials.gov/study/NCT06925321",
"title": "An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955728",
"publication_url": "https://clinicaltrials.gov/study/NCT06955728",
"title": "A Phase-IIIb Individually Randomized, Placebo-controlled Trial on Safety of RSVA/B-preF Vaccine in Pregnant Women and Efficacy Against Severe RSV-associated Lower Respiratory Tract Infection in Infants",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Witwatersrand, South Africa",
"sponsor_slug": "university-of-witwatersrand-south-africa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521476",
"publication_url": "https://clinicaltrials.gov/study/NCT06521476",
"title": "Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanjay R Patel",
"sponsor_slug": "sanjay-r-patel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800963",
"publication_url": "https://clinicaltrials.gov/study/NCT06800963",
"title": "ResQ133A-NMIBC: Phase 1/2 Clinical Trial of Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221851",
"publication_url": "https://clinicaltrials.gov/study/NCT07221851",
"title": "A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma A/S",
"sponsor_slug": "ascendis-pharma-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284875",
"publication_url": "https://clinicaltrials.gov/study/NCT07284875",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288320",
"publication_url": "https://clinicaltrials.gov/study/NCT07288320",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder Who Are Currently Experiencing a Manic Episode or Manic Episode With Mixed Features, With or Without Psychotic Symptoms, and Warrant Inpatient Hospitalization",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07818135",
"publication_url": "https://clinicaltrials.gov/study/NCT07818135",
"title": "Clinical Trial in Patients With Non-Small Cell Lung Cancer Undergoing Biportal Versus Multiportal Robotic Thoracic Surgery: Comparison of Two Innovative Techniques",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Carlos Déniz",
"sponsor_slug": "carlos-deniz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201519",
"publication_url": "https://clinicaltrials.gov/study/NCT07201519",
"title": "Phase IIa Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J Cavnar, MD",
"sponsor_slug": "michael-j-cavnar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07494305",
"publication_url": "https://clinicaltrials.gov/study/NCT07494305",
"title": "A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With Major Depressive Episodes Associated With Bipolar I Disorder",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "LB Pharmaceuticals Inc.",
"sponsor_slug": "lb-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07412756",
"publication_url": "https://clinicaltrials.gov/study/NCT07412756",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Major Depressive Disorder (RENEW-MDD 1)",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743268",
"publication_url": "https://clinicaltrials.gov/study/NCT07743268",
"title": "An Open-label Study of an Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis (ALS) Due to TARDBP (TDP-43) Genetic Mutation",
"has_exemption": false,
"start_date": "2026-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "n-Lorem Foundation",
"sponsor_slug": "n-lorem-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07817147",
"publication_url": "https://clinicaltrials.gov/study/NCT07817147",
"title": "Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer",
"has_exemption": false,
"start_date": "2026-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Banner Health",
"sponsor_slug": "banner-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192731",
"publication_url": "https://clinicaltrials.gov/study/NCT07192731",
"title": "Treatment of LIVER-limited HepatoCellular Carcinoma (HCC) in Patients With Preserved Liver Function by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191548",
"publication_url": "https://clinicaltrials.gov/study/NCT07191548",
"title": "Treatment of LIVER METastases From Colorectal Cancer by IRreversible Electroporation: A Prospective, International, Multi-centre Cohort Study.",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434635",
"publication_url": "https://clinicaltrials.gov/study/NCT07434635",
"title": "APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07492160",
"publication_url": "https://clinicaltrials.gov/study/NCT07492160",
"title": "Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms After 12-18 Week Abortion or Pregnancy Loss: A Pilot and Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Jefferson Drapkin",
"sponsor_slug": "jefferson-drapkin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07382674",
"publication_url": "https://clinicaltrials.gov/study/NCT07382674",
"title": "Zesty Exercise System for Therapeutic Engagement",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416604",
"publication_url": "https://clinicaltrials.gov/study/NCT07416604",
"title": "A Multicenter, Randomized, Open-Label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of NXT007 Prophylaxis Versus Emicizumab Prophylaxis in People With Hemophilia A",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285005",
"publication_url": "https://clinicaltrials.gov/study/NCT07285005",
"title": "A Phase 3, Randomized, Parallel, Multicenter, Double-blind, Placebo-controlled Study to Investigate Efficacy and Safety of KP 001 in Patients Aged ≥2 Years With Common Venous Malformations, Common Lymphatic Malformations, or KTS/CLOVES Syndrome",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Kaken Pharmaceutical",
"sponsor_slug": "kaken-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428616",
"publication_url": "https://clinicaltrials.gov/study/NCT07428616",
"title": "A Phase 2, Single-Arm, Multicenter, Open-Label Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226063",
"publication_url": "https://clinicaltrials.gov/study/NCT07226063",
"title": "A Phase II Study of Maintenance Zanzalintinib and Durvalumab in Patients With Advanced Hepatocellular Cancer After Induction Tremelimumab Plus Durvalumab",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amit Mahipal",
"sponsor_slug": "amit-mahipal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286331",
"publication_url": "https://clinicaltrials.gov/study/NCT07286331",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy",
"has_exemption": false,
"start_date": "2026-06-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07693452",
"publication_url": "https://clinicaltrials.gov/study/NCT07693452",
"title": "Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07621237",
"publication_url": "https://clinicaltrials.gov/study/NCT07621237",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Tonix Pharmaceuticals, Inc.",
"sponsor_slug": "tonix-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07534709",
"publication_url": "https://clinicaltrials.gov/study/NCT07534709",
"title": "Suzetrigine Versus Placebo for Opioid-Free Recovery After Cesarean Delivery: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419205",
"publication_url": "https://clinicaltrials.gov/study/NCT06419205",
"title": "A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 16 Years or Older With Immunoglobulin A Nephropathy (IgAN), Lupus Nephritis (LN), or Complement Component 3 Glomerulopathy (C3G)",
"has_exemption": false,
"start_date": "2026-07-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Akebia Therapeutics",
"sponsor_slug": "akebia-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07817173",
"publication_url": "https://clinicaltrials.gov/study/NCT07817173",
"title": "A Pilot Study Using Hyperthermic Irrigation Followed by Intravesical Chemotherapy in Patients With Low- to Intermediate-Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "CAMC Health System",
"sponsor_slug": "camc-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07789730",
"publication_url": "https://clinicaltrials.gov/study/NCT07789730",
"title": "Pilot Study Assessing the Feasibility of CAPA-IVM in Participants With Good Ovarian Reserve",
"has_exemption": false,
"start_date": "2026-08-26",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Inception Fertility Research Institute, LLC",
"sponsor_slug": "inception-fertility-research-institute-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465718",
"publication_url": "https://clinicaltrials.gov/study/NCT07465718",
"title": "Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.",
"has_exemption": false,
"start_date": "2026-09-03",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Orphalan",
"sponsor_slug": "orphalan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07673614",
"publication_url": "https://clinicaltrials.gov/study/NCT07673614",
"title": "Improving Sensorimotor Function in CIPN: A Randomized, Sham Controlled, Double Blinded, Crossover Mechanistic Trial of Transcranial Direct Current to the Sensorimotor Cortex",
"has_exemption": false,
"start_date": "2026-09-10",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07836647",
"publication_url": "https://clinicaltrials.gov/study/NCT07836647",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Transcend Therapeutics",
"sponsor_slug": "transcend-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845721",
"publication_url": "https://clinicaltrials.gov/study/NCT07845721",
"title": "Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "CooperVision International Limited (CVIL)",
"sponsor_slug": "coopervision-international-limited-cvil",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07752745",
"publication_url": "https://clinicaltrials.gov/study/NCT07752745",
"title": "Mechanistic Validation of Human Multipolar TES-TI: Amplitude Modulation, Frequency, and Benchmarking",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07837869",
"publication_url": "https://clinicaltrials.gov/study/NCT07837869",
"title": "Phase 1/2 Dose-Escalation Study of Epoprostenol as Adjunct Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation (ECMO)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Garrett Keim",
"sponsor_slug": "garrett-keim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07861126",
"publication_url": "https://clinicaltrials.gov/study/NCT07861126",
"title": "A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Assess the Efficacy and Safety of Sovateltide in Patients With Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmazz, Inc.",
"sponsor_slug": "pharmazz-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07355231",
"publication_url": "https://clinicaltrials.gov/study/NCT07355231",
"title": "Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Xemed LLC",
"sponsor_slug": "xemed-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428681",
"publication_url": "https://clinicaltrials.gov/study/NCT07428681",
"title": "Preventive Administration of Lorazepam in Critically Ill Patients With High Anttila-Index to Reduce the Incidence of Intensive Care Delirium: a Single-centre, Randomized, Controlled Clinical Trial - the Basel LOC2DEL-Trial",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Basel, Switzerland",
"sponsor_slug": "university-hospital-basel-switzerland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114679",
"publication_url": "https://clinicaltrials.gov/study/NCT07114679",
"title": "Molecular Breast Imaging (MBI)-Guided Biopsy Pilot SBIR",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Smart Breast Corp.",
"sponsor_slug": "smart-breast-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02991469",
"publication_url": "https://clinicaltrials.gov/study/NCT02991469",
"title": "An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, With Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase",
"has_exemption": false,
"start_date": "2018-08-09",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03793166",
"publication_url": "https://clinicaltrials.gov/study/NCT03793166",
"title": "PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]",
"has_exemption": false,
"start_date": "2019-06-07",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404088",
"publication_url": "https://clinicaltrials.gov/study/NCT04404088",
"title": "A Phase II Study of Acalabrutinib, Lenalidomide, and Rituximab (aR2) in Patients With Previously Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-07-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04560322",
"publication_url": "https://clinicaltrials.gov/study/NCT04560322",
"title": "A Phase 2 Study of MRD Adapted Therapy With Venetoclax-obinutuzumab in Patients With High or Intermediate BALL Risk Relapsed or Refractory CLL, With Addition of Acalabrutinib in Patients Who Fail to Achieve MRD Eradication",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747912",
"publication_url": "https://clinicaltrials.gov/study/NCT04747912",
"title": "A Phase II Study of a Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia (ALL) Incorporating Inotuzumab Ozogamicin (InO)",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04394858",
"publication_url": "https://clinicaltrials.gov/study/NCT04394858",
"title": "A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma",
"has_exemption": false,
"start_date": "2021-03-17",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871139",
"publication_url": "https://clinicaltrials.gov/study/NCT04871139",
"title": "Contrast-Enhanced Mammography (CEM) for the Evaluation and Targeted Biopsy of Suspicious Mammographic Architectural Distortions",
"has_exemption": false,
"start_date": "2021-04-08",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04941274",
"publication_url": "https://clinicaltrials.gov/study/NCT04941274",
"title": "A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2021-09-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05488431",
"publication_url": "https://clinicaltrials.gov/study/NCT05488431",
"title": "Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Priscilla Hsue, MD",
"sponsor_slug": "priscilla-hsue-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05727904",
"publication_url": "https://clinicaltrials.gov/study/NCT05727904",
"title": "A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05706025",
"publication_url": "https://clinicaltrials.gov/study/NCT05706025",
"title": "Pilot Study to Evaluate Utility of EnteroTracker® as a Minimally Invasive Sampling Method to Screen for Barrett's Esophagus and Esophageal Cancer",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535361",
"publication_url": "https://clinicaltrials.gov/study/NCT05535361",
"title": "A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eclipse Regenesis, Inc.",
"sponsor_slug": "eclipse-regenesis-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05758701",
"publication_url": "https://clinicaltrials.gov/study/NCT05758701",
"title": "Dual Energy CT Decreased IV Contrast Dose Imaging for TAVR",
"has_exemption": false,
"start_date": "2023-09-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097468",
"publication_url": "https://clinicaltrials.gov/study/NCT06097468",
"title": "A Phase I/IIa, Single-Arm, Dose-Confirmation and Dose-Expansion Study Evaluating Changes in the Oral Microbiome of Patients With Oral Cavity Squamous Cell Carcinoma (OSCC) After Short-Term Ingestion of Nisin, a Naturally Occurring Food Preservative",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06266546",
"publication_url": "https://clinicaltrials.gov/study/NCT06266546",
"title": "Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Youssef Yammine",
"sponsor_slug": "youssef-yammine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06633913",
"publication_url": "https://clinicaltrials.gov/study/NCT06633913",
"title": "Neural Effects of Transcranial Magnetic Stimulation Using Concurrent Functional Magnetic Resonance Imaging",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jing Jiang",
"sponsor_slug": "jing-jiang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06275776",
"publication_url": "https://clinicaltrials.gov/study/NCT06275776",
"title": "The Effect of Suturing Techniques on Aberrant Wound Recovery After Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Reinier Haga Orthopedisch Centrum",
"sponsor_slug": "reinier-haga-orthopedisch-centrum",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157099",
"publication_url": "https://clinicaltrials.gov/study/NCT06157099",
"title": "A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06398106",
"publication_url": "https://clinicaltrials.gov/study/NCT06398106",
"title": "Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06675344",
"publication_url": "https://clinicaltrials.gov/study/NCT06675344",
"title": "A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592833",
"publication_url": "https://clinicaltrials.gov/study/NCT06592833",
"title": "Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216222",
"publication_url": "https://clinicaltrials.gov/study/NCT07216222",
"title": "Intracranial Recording and Stimulation of the Human Hippocampal-Amygdala Circuit During Virtual Reality Fear Conditioning",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06849713",
"publication_url": "https://clinicaltrials.gov/study/NCT06849713",
"title": "A Multicenter Phase 2 Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax (BOSon) or Tacabrutideg (BGB-16673), Obinutuzumab, and Sonrotoclax (DOSon) in Treatment-Naïve Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06962839",
"publication_url": "https://clinicaltrials.gov/study/NCT06962839",
"title": "A Randomised, Double-masked, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Oral BI 1815368 in Participants With Centre-involved Diabetic Macular Edema for 48 Weeks of Treatment (THULITE)",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959511",
"publication_url": "https://clinicaltrials.gov/study/NCT06959511",
"title": "ZAnzalintinib Neoadjuvant EValuation in Thyroid Oncology (ZANEVO)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07123454",
"publication_url": "https://clinicaltrials.gov/study/NCT07123454",
"title": "A Modular Phase I/II Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Efficacy of AZD4512 Monotherapy or in Combination With Other Anticancer Agent(s), in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) (Lumi-NHL)",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934239",
"publication_url": "https://clinicaltrials.gov/study/NCT06934239",
"title": "A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06971731",
"publication_url": "https://clinicaltrials.gov/study/NCT06971731",
"title": "A Phase 3, Double-Blind, Randomized, Two-Period, Multicenter, Placebo-Controlled, Efficacy and Safety Study of JNT-517 for the Treatment of Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025330",
"publication_url": "https://clinicaltrials.gov/study/NCT07025330",
"title": "A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377215",
"publication_url": "https://clinicaltrials.gov/study/NCT06377215",
"title": "Understanding Aided Speech Perception in Noise: Behavioral and Electrophysiological Measures",
"has_exemption": false,
"start_date": "2025-11-16",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of South Florida",
"sponsor_slug": "university-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318688",
"publication_url": "https://clinicaltrials.gov/study/NCT07318688",
"title": "A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-Associated Pain Over a 24-Week Treatment Period and a 28-Week Extension",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hope Medicine (Nanjing) Co., Ltd",
"sponsor_slug": "hope-medicine-nanjing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07270276",
"publication_url": "https://clinicaltrials.gov/study/NCT07270276",
"title": "The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369310",
"publication_url": "https://clinicaltrials.gov/study/NCT07369310",
"title": "Randomized Trial on DBS Programming Based on Biomarkers vs. Standard Monopolar Review",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau",
"sponsor_slug": "fundacio-institut-de-recerca-de-lhospital-de-la-santa-creu-i-sant-pau",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07403058",
"publication_url": "https://clinicaltrials.gov/study/NCT07403058",
"title": "Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Reduced Ejection Fraction: Randomized Controlled Feasibility Trial",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Axon Therapies, Inc.",
"sponsor_slug": "axon-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07394608",
"publication_url": "https://clinicaltrials.gov/study/NCT07394608",
"title": "Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405190",
"publication_url": "https://clinicaltrials.gov/study/NCT07405190",
"title": "A Phase II Study of Ivonescimab as Monotherapy or in Combination With Platinum/Pemetrexed Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring Actionable Genomic Alterations (AGAs)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07410598",
"publication_url": "https://clinicaltrials.gov/study/NCT07410598",
"title": "Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting",
"has_exemption": false,
"start_date": "2026-05-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265843",
"publication_url": "https://clinicaltrials.gov/study/NCT07265843",
"title": "Fibrinogen in Liver Transplant Subjects (FITS)",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Trauma Hemostatis and Oxygenation Research (THOR) Network",
"sponsor_slug": "trauma-hemostatis-and-oxygenation-research-thor-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07377526",
"publication_url": "https://clinicaltrials.gov/study/NCT07377526",
"title": "Phase 1/2 Study Of IL15-Transduced, TGFBR2 KO, TROP2 CAR- Engineered Cord Blood-Derived NK Cells Administered Intraperitoneally And Intravenously In Combination With Oral Belzutifan For The Management Of Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-05-26",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430917",
"publication_url": "https://clinicaltrials.gov/study/NCT07430917",
"title": "A Phase II, Randomized, Placebo-Controlled, Double-Blind, Adaptive Study to Assess the Safety and Efficacy of Intravenous J147 Combined With Endovascular Therapy in Patients With Acute Ischemic Stroke",
"has_exemption": false,
"start_date": "2026-07-22",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Abrexa Pharmaceuticals, Inc.",
"sponsor_slug": "abrexa-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07676331",
"publication_url": "https://clinicaltrials.gov/study/NCT07676331",
"title": "Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07251491",
"publication_url": "https://clinicaltrials.gov/study/NCT07251491",
"title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury",
"has_exemption": false,
"start_date": "2026-08-06",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "James J. Peters Veterans Affairs Medical Center",
"sponsor_slug": "james-j-peters-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07685743",
"publication_url": "https://clinicaltrials.gov/study/NCT07685743",
"title": "Extended Post-operative Oral TXA vs.Standard Perioperative TXA in Primary TJA: A Randomized, Double-Blind, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07763210",
"publication_url": "https://clinicaltrials.gov/study/NCT07763210",
"title": "A Phase 2 Trial of Early Enhanced Interventions to Prevent ICANS After CD19 CAR T Therapy in Patients With Non-Hodgkin Lymphoma: Lazarus Trial",
"has_exemption": false,
"start_date": "2026-09-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215858",
"publication_url": "https://clinicaltrials.gov/study/NCT07215858",
"title": "Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of the Safety and Efficacy of BPL-1357 Against H1N1 Influenza Virus Challenge",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07776964",
"publication_url": "https://clinicaltrials.gov/study/NCT07776964",
"title": "Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)",
"has_exemption": false,
"start_date": "2026-10-29",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07796802",
"publication_url": "https://clinicaltrials.gov/study/NCT07796802",
"title": "Continuous Glucose Monitoring vs Point of Care Glucose Measurements for In-hospital Type 2 Diabetes Management - STENO In-Hospital CGM Trial - a Multisite, Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Steno Diabetes Center Copenhagen",
"sponsor_slug": "steno-diabetes-center-copenhagen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07871669",
"publication_url": "https://clinicaltrials.gov/study/NCT07871669",
"title": "A Phase II, Multi-center, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2028-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Wuhan Kangfude Urolithiasis Research Institute Co., Ltd.",
"sponsor_slug": "wuhan-kangfude-urolithiasis-research-institute-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03571945",
"publication_url": "https://clinicaltrials.gov/study/NCT03571945",
"title": "Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sir Ganga Ram Hospital",
"sponsor_slug": "sir-ganga-ram-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05732402",
"publication_url": "https://clinicaltrials.gov/study/NCT05732402",
"title": "An Open-Label, Multiple-Ascending Dose Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Different Dose Levels of Povetacicept in Subjects With Autoantibody-Associated Glomerular Diseases (RUBY-3)",
"has_exemption": false,
"start_date": "2023-03-15",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences, Inc.",
"sponsor_slug": "alpine-immune-sciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07586202",
"publication_url": "https://clinicaltrials.gov/study/NCT07586202",
"title": "A Phase 2 Study Evaluating the Safety and Efficacy of Neoadjuvant Amivantamab in Combination With Lazertinib or Chemotherapy in Resectable EGFR-Mutated Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402332",
"publication_url": "https://clinicaltrials.gov/study/NCT05402332",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05834296",
"publication_url": "https://clinicaltrials.gov/study/NCT05834296",
"title": "Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 1/2a Study to Assess Safety, Tolerability & Efficacy of Autologous Beta-Amyloid Mutant Peptide-pulsed Dendritic Cells in Subjects With Mild-to-Moderate Alzheimer's Dementia",
"has_exemption": false,
"start_date": "2023-07-05",
"completion_date": "2028-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Alzamend Neuro, Inc.",
"sponsor_slug": "alzamend-neuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07040319",
"publication_url": "https://clinicaltrials.gov/study/NCT07040319",
"title": "Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2028-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447063",
"publication_url": "https://clinicaltrials.gov/study/NCT07447063",
"title": "The Impact of Dietary Salt on the Severity of Eczema",
"has_exemption": false,
"start_date": "2026-08-10",
"completion_date": "2028-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03471650",
"publication_url": "https://clinicaltrials.gov/study/NCT03471650",
"title": "A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA",
"has_exemption": false,
"start_date": "2018-03-29",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05142696",
"publication_url": "https://clinicaltrials.gov/study/NCT05142696",
"title": "A Phase Ib/II Dose Finding Study Assessing Safety and Efficacy of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide, and Atezolizumab in Induction and With Atezolizumab in Maintenance Phase",
"has_exemption": false,
"start_date": "2022-07-13",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284420",
"publication_url": "https://clinicaltrials.gov/study/NCT07284420",
"title": "An ISA to Master Protocol ARGX-999-2-MG-2000 for an Exploratory, Phase 2a, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV as Add-On Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2028-03-07",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05611242",
"publication_url": "https://clinicaltrials.gov/study/NCT05611242",
"title": "Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2028-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercy Health, Ohio",
"sponsor_slug": "mercy-health-ohio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852963",
"publication_url": "https://clinicaltrials.gov/study/NCT06852963",
"title": "A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "PYC Therapeutics",
"sponsor_slug": "pyc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928662",
"publication_url": "https://clinicaltrials.gov/study/NCT06928662",
"title": "Sequential Decitabine in Combination With FLAG-Ida Followed Immediately by Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (DEC-FLAG-Ida/RIC) for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1/2 Study",
"has_exemption": false,
"start_date": "2025-09-23",
"completion_date": "2028-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04276870",
"publication_url": "https://clinicaltrials.gov/study/NCT04276870",
"title": "CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)",
"has_exemption": false,
"start_date": "2020-03-12",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephan Grupp MD PhD",
"sponsor_slug": "stephan-grupp-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144280",
"publication_url": "https://clinicaltrials.gov/study/NCT07144280",
"title": "PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335588",
"publication_url": "https://clinicaltrials.gov/study/NCT07335588",
"title": "A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream in Adult Participants With Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "LEO Pharma",
"sponsor_slug": "leo-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07765888",
"publication_url": "https://clinicaltrials.gov/study/NCT07765888",
"title": "A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED PHASE 3 COMBINATION THERAPY STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF TILREKIMIG IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE OR OLDER WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2026-08-17",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07689188",
"publication_url": "https://clinicaltrials.gov/study/NCT07689188",
"title": "An Open-Label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-09-10",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Harrison Dermatology",
"sponsor_slug": "harrison-dermatology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07615686",
"publication_url": "https://clinicaltrials.gov/study/NCT07615686",
"title": "Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Bailey Petersen",
"sponsor_slug": "bailey-petersen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926868",
"publication_url": "https://clinicaltrials.gov/study/NCT06926868",
"title": "IZABRIGHT-Breast01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment",
"has_exemption": false,
"start_date": "2025-09-11",
"completion_date": "2028-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453044",
"publication_url": "https://clinicaltrials.gov/study/NCT06453044",
"title": "A Phase 2 Study of Mosunetuzumab With Polatuzumab Vedotin in Patients With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07792954",
"publication_url": "https://clinicaltrials.gov/study/NCT07792954",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-WEEKLY PF-08653944 IN CHINESE ADULTS WITH OVERWEIGHT OR OBESITY",
"has_exemption": false,
"start_date": "2026-09-24",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224932",
"publication_url": "https://clinicaltrials.gov/study/NCT07224932",
"title": "A Randomized, Double-blind, Placebo-controlled Parallel Study of the Tolerability and Efficacy of High Cannabidiol (CBD) Cannabis Extract for the Treatment of Patients With Idiopathic Restless Legs Syndrome (RLS)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2028-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01295645",
"publication_url": "https://clinicaltrials.gov/study/NCT01295645",
"title": "A Phase II Randomized Study of Cidofovir Versus Best Supportive Care for Polyomavirus Hominis Type I (BK) Virus Related Hemorrhagic Cystitis After Stem Cell Transplant",
"has_exemption": false,
"start_date": "2011-03-17",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06245109",
"publication_url": "https://clinicaltrials.gov/study/NCT06245109",
"title": "Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616766",
"publication_url": "https://clinicaltrials.gov/study/NCT06616766",
"title": "A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuhan Corporation",
"sponsor_slug": "yuhan-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747611",
"publication_url": "https://clinicaltrials.gov/study/NCT06747611",
"title": "Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483320",
"publication_url": "https://clinicaltrials.gov/study/NCT07483320",
"title": "A Randomized Controlled Trial Evaluating the Influence of Physical Therapy, Shockwave Therapy, Platelet Rich Plasma or Combined Treatment in the Management of Midportion Achilles Tendinopathy",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07871214",
"publication_url": "https://clinicaltrials.gov/study/NCT07871214",
"title": "ROSETTA Lung-220: A Phase 2, Open-Label, Multicenter, Multi-Arm Platform Study Evaluating Pumitamig and Other Novel Neoadjuvant Regimens in Participants With Resectable, Early-Stage (IIA to IIIB) Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722235",
"publication_url": "https://clinicaltrials.gov/study/NCT06722235",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants With Chronic Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07850739",
"publication_url": "https://clinicaltrials.gov/study/NCT07850739",
"title": "A Phase 2, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBIP-01435 in Adults With Classic Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07487831",
"publication_url": "https://clinicaltrials.gov/study/NCT07487831",
"title": "The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease",
"has_exemption": false,
"start_date": "2026-07-14",
"completion_date": "2028-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07842159",
"publication_url": "https://clinicaltrials.gov/study/NCT07842159",
"title": "Long-acting Local Vaginal Cuff Anesthesia Following Hysterectomy: LAVA Trial",
"has_exemption": false,
"start_date": "2026-09-17",
"completion_date": "2028-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06873945",
"publication_url": "https://clinicaltrials.gov/study/NCT06873945",
"title": "A PHASE 3, EXTERNAL AND SYNTHETIC PLACEBO-CONTROLLED RANDOMIZED STUDY WITH DOSE-UP FOR NON-RESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG AND 100 MG ONCE DAILY IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH ALOPECIA AREATA",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2028-03-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305247",
"publication_url": "https://clinicaltrials.gov/study/NCT06305247",
"title": "An Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2028-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05025800",
"publication_url": "https://clinicaltrials.gov/study/NCT05025800",
"title": "A Phase I/II Open Label, Single Center, Study of the Combination of ALX148, Rituximab and Lenalidomide in Patients With Indolent and Aggressive B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2021-10-13",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05160922",
"publication_url": "https://clinicaltrials.gov/study/NCT05160922",
"title": "CRIZOTINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED CRIZOTINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2021-12-27",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04804553",
"publication_url": "https://clinicaltrials.gov/study/NCT04804553",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)",
"has_exemption": false,
"start_date": "2022-03-17",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350097",
"publication_url": "https://clinicaltrials.gov/study/NCT06350097",
"title": "A Phase III, Open-label, Randomised Study of Osimertinib With or Without Datopotamab Deruxtecan (Dato-DXd), as First-line Treatment in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597019",
"publication_url": "https://clinicaltrials.gov/study/NCT06597019",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children (6 to Less Than 12 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL- Cholesterol",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597006",
"publication_url": "https://clinicaltrials.gov/study/NCT06597006",
"title": "Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03412877",
"publication_url": "https://clinicaltrials.gov/study/NCT03412877",
"title": "A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in Patients With Metastatic Cancer",
"has_exemption": false,
"start_date": "2018-09-06",
"completion_date": "2028-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949684",
"publication_url": "https://clinicaltrials.gov/study/NCT05949684",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System (IPSS-R) Very Low, Low, or Intermediate-Risk Myelodysplastic Syndrome (MDS) in Erythropoiesis-Stimulating Agent (ESA)-Naive Participants Who Are Non-Transfusion Dependent (NTD): The \"ELEMENT-MDS\" Trial",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06141486",
"publication_url": "https://clinicaltrials.gov/study/NCT06141486",
"title": "A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-12-27",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221188",
"publication_url": "https://clinicaltrials.gov/study/NCT07221188",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332455",
"publication_url": "https://clinicaltrials.gov/study/NCT07332455",
"title": "A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Dose Optimization Study of GSK5471713 in Adult Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07476287",
"publication_url": "https://clinicaltrials.gov/study/NCT07476287",
"title": "A PHASE 2 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED TRANSFORMED SMALL CELL LUNG CANCER",
"has_exemption": false,
"start_date": "2026-07-02",
"completion_date": "2028-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213973",
"publication_url": "https://clinicaltrials.gov/study/NCT07213973",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2028-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05530421",
"publication_url": "https://clinicaltrials.gov/study/NCT05530421",
"title": "Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)",
"has_exemption": false,
"start_date": "2023-03-26",
"completion_date": "2028-03-26",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284901",
"publication_url": "https://clinicaltrials.gov/study/NCT07284901",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616910",
"publication_url": "https://clinicaltrials.gov/study/NCT05616910",
"title": "Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2028-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}